Pharmacists promote rational use of antibiotic prophylaxis in Type I incision operations via application of drug use evaluation

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 9, 2013, Pages 704-710

  Shi, Qing Ping ^a   Ding, Feng ^a   Liu, Yan ^a   Sang, Ran ^a   Zhu, Jin Xiu ^a   Shi, Pei Lan ^a   Wang, Mu Hua ^a   Yuan, Hao Yu ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b Hegongye 416 Hospital   (China)

Author keywords

Antibiotic prophylaxis; Drug use evaluation; Perioperative period; Type I incision operations

Indexed keywords

ANTIBIOTIC AGENT; CEFATHIAMIDINE; CEFAZOLIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHINA; CLINICAL PRACTICE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG CHOICE; DRUG COST; DRUG INDICATION; DRUG MONITORING; DRUG USE; FEMALE; HEALTH PROMOTION; HUMAN; INAPPROPRIATE PRESCRIBING; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PHARMACIST; PRESCRIPTION; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; SURGICAL INFECTION; SURGICAL TECHNIQUE; TREATMENT DURATION; TYPE 1 INCISION;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; PHARMACISTS; RETROSPECTIVE STUDIES;

EID: 84885030660     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201895     Document Type: Article

References (20)

1. Wendy M. Antibiotics for surgical prophylaxis. Australian Prescriber. 2005; 28: 38-40.
2. Page C.P., Bohnen JM, Fletcher J.R., McManus AT, Solomkin JS, Wittmann DH Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg. 1993; 128: 79-88. (Pubitemid 23027028)
3. CrossRef Published erratum appears in Arch Surg. 1993; 128: 410.
4. Fonseca SN, Kunzle SR, Junqueira M.J., Nascimento RT, de Andrade JI, Levin AS Implementing 1-dose antibiotic prophylaxis for prevention of surgical site infection. Arch Surg. 2006; 141: 1109-1113. (Pubitemid 44790540)
5. Antimicrobial prophylaxis in surgery [SIGN publication No.45]. Scottish Inter-collegiate Guideline Network Website. http://www.sign.ac.uk/guidelines/ fulltext/45/index.html. Accessed August 22, 2006.
6. Fonseca LG, de Oliveira Conterno L. Audit of antibiotic use in a Brazilian University Hospital. Braz J Infect Dis. 2004; 8: 272-280.
7. Chen R, Zhao Z, Wang X., et al Analysis of perioperative use of prophylactic antibiotics. China Pharm. 2008; 19: 573-575.
8. Vessal G, Namazi S, Davarpanah M.A., Foroughinia F. Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran. East Mediterr Health J. 2011; 17: 663-668.
9. Zhao Y, Hou Q, Gu K., et al Evaluation of use of antibacterials in 820 inpatients. Evaluation and analysis of drug use in hospitals of China. 2008; 8(2): 92-94.
10. Willems L, Simoens S, Laekeman G. Follow-up of antibiotic prophylaxis: impact on compliance with guidelines and financial outcomes. J Hosp Infect. 2005; 60: 333-339. (Pubitemid 40932089)
11. Jiang L, Shen A, Shi T., et al Rational use of antibiotics at perioperative period of Type I incision operations between a comparison pre- and postintervention. Chin J Nosocomiol. 2009; 19: 2166-2169.
12. Lu J, Xu T, Fan X., et al Investigation of the application of antibiotic during perioperative periode in 1268 patients. West China Med J. 2008; 23: 63-64.
13. Deresse D, Alemayehu T. Evaluation of the use of cotrimoxazole prophylaxis in people living with HIV/AIDS in Hawassa Referral Hospital: A retrospective evaluation. Asian J Med Sci. 2009; 1: 88-90.
14. American Society of Health-System Pharmacists. ASHP Statement on the pharmacist's role in antimicrobial stewardship and infection. Am J Health Syst Pharm. 2010; 67: 575-576.
15. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999; 56: 1839-1888.
16. Pulver LK, Wa i A, Maxwell D F, Robertson MB Riddell S. Implementation and evaluation of a multisite drug usage evaluation program across Australian hospitals - A quality improvement initiative. BMC Health Serv Res. 2011; 11: 206-214.
17. Raveh D, Muallem-Zilcha E, Greenberg A., WienerWell Y, Schlesinger Y, Yinnon AM Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem. QJM. 2006; 99: 397-406. (Pubitemid 43985778)
18. Schweizer ML, Furuno JP, Harris A.D., Johnson JK, Shardell MD, McGregor JC, Thom K.A., Cosgrove SE, Sakoulas G, Perencevich EN Comparative effectiveness of naficillin or cefazolin versus vancomycin in methicillin-susceptible Staphylo-coccus aureus bacteremia. BMC Infect Dis. 2011; 11: 279-285. http://www.biomedcentral.Com/1471-2334/11/279. 2006; 99: 397-406.
19. DeLeo FR, Chambers H F. Reemergence of antibiotic-resistant Staphylococcus aureus in the ge-nomics era. J Clin Invest. 2009; 119: 2464-2474.
20. Xinqian C., Youyu J, Tang G. New pharmacology (The seventeenth Edition), People's Medical Publishing House 2011; 12: 48-53.